Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)


Tuesday 02 October, 2018

Benchmark Hlgs PLC

Appointment of Chief Scientific Officer

RNS Number : 6049C
Benchmark Holdings PLC
02 October 2018

2 October 2018


Benchmark Holdings plc
("Benchmark" or the "Company")


Appointment of Chief Scientific Officer


Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, is pleased to announce that, further to its announcement on 2 July 2018 of the appointment of Dr Alex Raeber as Chief Scientific Officer, Dr Raeber has now joined the board and commenced his role at the Company.


Malcolm Pye, Chief Executive of Benchmark, said:


"I am delighted that Alex has now joined Benchmark as Chief Scientific Officer. I very much look forward to working closely with him in the next stage of our exciting development."


-      Ends      -


For further information, please contact:


Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations

Rachel Aninakwah, Communications




Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)




Tel: 020 3128 8742

Katie Hunt / Reg Hoare /Alistair de Kare-Silver

[email protected]



Notes to Editors:

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, advanced nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way.


The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 31 March 2018, it employed 1028 people.


For further information on Benchmark please visit / @WeAreBenchmark




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t